<div>
  <ul>
    <li>
      <p>
        Tiamat Sciences, the California-based biotechnology company, raised USD 2 million in a seed extension financing round. The round was led by 8090 Industries, with participation from new and existing investors including True Ventures, Social impact capital, Cantos, Portfolia, Alexandria, Siddhi Capital, and others.
      </p>
    </li>
    <li>
      <p>
        The new funds will be used to accelerate product validation in the cellular agriculture and regenerative medicine markets and establish strategic partnerships with industry leaders.&nbsp;
      </p>
    </li>
    <li>
      <p>
        The latest funding round comes at a pivotal stage for Tiamat as it prepares for commercial production of its proprietary animal-free recombinant proteins in March 2023 and on the back of a new patented product which it claims will promote an increase of 1000x of the yield within six months.
      </p>
    </li>
  </ul>
  <p>
  </p>
</div>


<div>
  <p>
    <a href="https://www.prnewswire.com/news-releases/female-owned-biotech-startup-tiamat-sciences-raise-an-extension-of-2m-to-accelerate-product-validation-and-strategic-partnerships-301766037.html">
      Press release
    </a>
  </p>
</div>


Cell-cultured Meat

Tiamat Sciences raise an extension of USD 2 million

Bringing fresh produce closer to consumers with efficient, advanced technology.

All Updates

Tiamat Sciences raise an extension of USD 2 million

Urban Crop Solutions supplies Tiamat Sciences with tech to grow animal-free protein

Tiamat sciences partners with vertical farming solutions company Urban Crop Solutions